Description
Hydroxyurea capsules 500 mg provide a trusted, oral solution for patients needing to reduce painful sickle‑cell crises and control abnormal cell growth in specific cancers. By increasing fetal hemoglobin levels, the medication improves red‑blood‑cell flexibility, decreasing blockage and pain episodes. Clinically validated for safety and efficacy, it offers a convenient daily regimen that supports better quality of life and disease management under physician guidance.